B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL)

Clinical trials for B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL) explained in plain language.

Never miss a new study

Get alerted when new B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL) trials appear

Sign up with your email to follow new studies for B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New cell therapy trial targets tough blood cancers and anemia

Disease control Recruiting now

This early-phase study is testing a new cell therapy called GT801 in adults with advanced blood cancers or autoimmune anemia that has not responded to standard treatments. The main goals are to check if the treatment is safe and to see early signs of whether it helps control the …

Matched conditions: B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL)

Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL)

Get alerted when new B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL) trials appear

New cell therapy trial targets tough blood cancers and anemia